InvestorsHub Logo
Followers 24
Posts 819
Boards Moderated 0
Alias Born 04/15/2007

Re: None

Thursday, 07/23/2020 8:14:40 AM

Thursday, July 23, 2020 8:14:40 AM

Post# of 83386

The new patent application has been published .CVSI submitted this immediately after the patent in May was granted. Looks like higher doses and more delivery methods.(tablets, pills, nasal, transdermally)

United States Patent Application 20200230077
Kind Code A1
Williams; Jonnie R. July 23, 2020
Pharmaceutical Formulations Containing Cannabidiol and Nicotine for Treating Smokeless Tobacco Addiction

Abstract
In one aspect, a method of treating smokeless tobacco addiction comprising administering to an individual in need thereof a pharmaceutical composition comprising nicotine, a therapeutically effective amount of cannabidiol, and a pharmaceutically acceptable vehicle therefor. In some aspects, the composition is administered transmucosally, such as in an oral dosage form or nasal spray. In other aspects, the composition is administered transdermally. In another aspect, a chewable gum contains nicotine in at least a base portion and cannabidiol in at least an outer portion thereof